Cart

0

Stocks

“These 2 Penny Stocks Could Surge Over 300%, Say Analysts”

“AcelRx Pharmaceuticals (ACRX)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, ACRX has a Strong Buy consensus rating. Based on the $7 average price target,… Continue Reading…